Skip to main content

Tissue Distribution of Intravenously Administrated Hydroxyapatite Nanoparticles Labeled with 125I

Buy Article:

$113.00 plus tax (Refund Policy)

Abstract:

Hydroxyapatite nanoparticles (HANPs) have been developed for biomedical use due to its extraordinary properties. However, the side effects of HANPs on human body have also been concerned, especially in vivo. Now it is still unknown how about the distribution and biobehavior of HANPs in vivo is, though it's very important for application in biosystem. This study was to establish a new method of 125I radiolabeling on HANPs at 80 nm, investigate the long-term tissue distribution of HANPs quantitatively after intravenously administrated HANPs labeled with 125I and the subcellular distribution in liver and spleen by TEM. The results indicated the labeled HANPs had high stability in vitro, and could accumulate mainly in the liver and spleen and decrease in time dependent manner, but still retain in body for more than 28 days. This stagnation most probably attribute to the endocytosis by macrophages in these tissues. The results implied the radioactive iodine labeling was an effective and sensitive method for tracing and analyzing the distribution of NPs in vivo. Liver and spleen should be the main target organ reached when HANPs were injected into circulation system. Because HANPs could stay in vivo for over one month, the biosafety shouldn't be neglected.

Keywords: HYDROXYAPATITE NANOPARTICLES; MACROPHAGE; NANOTOXICITY; RADIOLABELLING; TISSUE DISTRIBUTION

Document Type: Research Article

DOI: http://dx.doi.org/10.1166/jnn.2011.3956

Publication date: December 1, 2011

More about this publication?
  • Journal for Nanoscience and Nanotechnology (JNN) is an international and multidisciplinary peer-reviewed journal with a wide-ranging coverage, consolidating research activities in all areas of nanoscience and nanotechnology into a single and unique reference source. JNN is the first cross-disciplinary journal to publish original full research articles, rapid communications of important new scientific and technological findings, timely state-of-the-art reviews with author's photo and short biography, and current research news encompassing the fundamental and applied research in all disciplines of science, engineering and medicine.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
asp/jnn/2011/00000011/00000012/art00144
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more